Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Infection and Chemotherapy
Published in: Journal of Infection and Chemotherapy 3/1999

01-09-1999 | NOTE

Comparative in vitro activity of carbapenem antibiotics against respiratory pathogens isolated in recent years

Authors: A. Watanabe, Hiroaki Kikuchi, Tohru Kikuchi, Afzalunnesa Binte Lutfor, Yutaka Tokue, Hiroshi Takahashi, Shigeru Fujimura, Satoru Shoji, Yoshihiro Honda, Yushi Nakai, Toshihiro Nukiwa

Published in: Journal of Infection and Chemotherapy | Issue 3/1999

Login to get access
Metadata
Title
Comparative in vitro activity of carbapenem antibiotics against respiratory pathogens isolated in recent years
Authors
A. Watanabe
Hiroaki Kikuchi
Tohru Kikuchi
Afzalunnesa Binte Lutfor
Yutaka Tokue
Hiroshi Takahashi
Shigeru Fujimura
Satoru Shoji
Yoshihiro Honda
Yushi Nakai
Toshihiro Nukiwa
Publication date
01-09-1999
Publisher
Springer-Verlag
Published in
Journal of Infection and Chemotherapy / Issue 3/1999
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s101560050029

Other articles of this Issue 3/1999

Journal of Infection and Chemotherapy 3/1999 Go to the issue

ORIGINAL ARTICLE

Effect of anticancer agents on Fas-mediated cytotoxicity against bladder cancer cells

ORIGINAL ARTICLE

Pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogenase indicate chemosensitivity of human colon cancer specimens to doxifluridine and 5-fluorouracil, respectively

NOTE

Estimation of outer membrane permeability of carbapenem antibiotics to Pseudomonas aeruginosa

ORIGINAL ARTICLE

In vitro antimicrobial activity and penetration rate into sputum of gatifloxacin, a novel 6-fluoro-8-methoxy quinolone, and its therapeutic efficacy in respiratory infections

ORIGINAL ARTICLE

Candida glabrata fungemia in a tertiary cancer institution in Slovakia

ORIGINAL ARTICLE

Influence of gatifloxacin, a new quinolone antibacterial, on pharmacokinetics of theophylline
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits